Purpose: This study was designed to evaluate the resistin levels in GCF of patients suffering from periodontitis and type 2 diabetes mellitus (T2DM) after non-surgical periodontal therapy and subantimicrobial dosage of doxycycline (SDD). Materials and methods: Thirty periodontal sites within 24 patients with age ranging between (24-51) years old were selected for this study. A total of 30 periodontal sites were randomly divided into three groups; each group included ten periodontal sites: (group I): systemically healthy periodontitis patients who had received scaling and root planning (SRP), (group II): periodontitis patients with T2DM who had received SRP, and (group III): periodontitis patients with T2DM who were received SRP and SDD 20mg twice/day. All patients were examined with the same clinical periodontal parameters which are plaque index (PI), gingival index (GI), probing depth (PD) and clinical attachment level (CAL). Patients in each group went through nonsurgical periodontal therapy as well as a maintenance program (which includes brushing with regular toothpaste). Collection of GCF samples was done in all patients at baseline, one month and 3 month following the periodontal therapy. Quantification of resistin in human samples was measured using resistin ELISA test. Results: Non-surgical periodontal therapy was found to show relative improvement in all clinical parameters as well as a decline in resistin levels. In addition, GCF levels of resistin, PD, GI showed greater reduction after non-surgical treatment in group III than group II. Conclusion: Non-surgical periodontal therapy is Codex : 07/2001
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.